Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Wooster › NPI 1437156247
Hospital

City of Wooster

City of Wooster was paid $13.99M by Medicaid between Jan 2018 and Nov 2024, across 222 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.

33Billing provider infoCITY OF WOOSTER
WOOSTER, OH 44691
33aNPI1437156247assigned 07/07/2005
28Total paid$13.99M
24GClaims354,413
24DCodes billed222
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#64 of 101
Median peer was paid$22.32M
This provider vs. median0.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201825,710$865K
201926,612$872K
202019,492$947K
202129,076$1.14M
202234,704$1.54M
2023132,206$4.97M
2024incomplete86,613$3.66M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 18% 23,436 21,094 $2.58M
96361 Intravenous infusion, hydration; each additional hour 15% 8,028 6,088 $2.17M
99282 Emergency department visit for the evaluation and management, low to moderate severity 14% 17,930 16,359 $2.00M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.7% 7,974 7,025 $936K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.2% 7,783 6,822 $870K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.0% 6,567 1,572 $425K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.0% 1,656 1,308 $424K
70450 Computed tomography, head or brain; without contrast material 2.8% 1,637 1,364 $397K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 2.5% 4,650 1,478 $347K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.7% 879 692 $243K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.7% 4,034 1,432 $233K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.4% 1,385 1,041 $195K
210 more codes
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.3% 928 $180K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.3% 1,530 $177K
80053 Comprehensive metabolic panel 1.2% 13,675 $169K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.1% 1,551 $148K
G0378 Hospital observation service, per hour <1% 1,550 $136K
80048 Basic metabolic panel (calcium, ionized) <1% 20,778 $120K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 339 $119K
71275 Computed tomographic angiography, chest, with contrast material <1% 456 $114K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 1,220 $114K
59025 Fetal non-stress test <1% 724 $112K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 38,206 $88K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 364 $84K
84443 Thyroid stimulating hormone (TSH) <1% 5,256 $78K
36415 Collection of venous blood by venipuncture <1% 26,779 $71K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 711 $60K
87631 <1% 883 $52K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 494 $41K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,029 $40K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,060 $36K
97162 <1% 676 $35K
97113 <1% 627 $33K
97161 <1% 490 $33K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 895 $33K
80061 Lipid panel <1% 2,672 $32K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,808 $31K
71046 Radiologic examination, chest; 2 views <1% 3,015 $28K
94668 <1% 244 $27K
86703 <1% 832 $27K
84439 <1% 1,344 $26K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 135 $24K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,541 $23K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,024 $22K
76830 Ultrasound, transvaginal <1% 399 $21K
97164 <1% 439 $21K
85027 <1% 3,751 $21K
94060 <1% 138 $20K
83036 Hemoglobin; glycosylated (A1C) <1% 1,824 $20K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 65 $20K
92508 Group treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 198 $19K
97803 <1% 244 $19K
77063 Screening digital breast tomosynthesis, bilateral <1% 429 $18K
86850 <1% 804 $17K
H2020 Therapeutic behavioral services, per diem <1% 96 $17K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 442 $17K
87070 <1% 1,021 $16K
82607 <1% 918 $15K
86780 <1% 782 $15K
95886 <1% 51 $14K
93971 <1% 169 $14K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 826 $14K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 106 $14K
97166 <1% 268 $13K
H2012 Behavioral health day treatment, per hour <1% 207 $13K
86900 <1% 931 $12K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 8,334 $12K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,327 $12K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 280 $12K
59050 <1% 779 $12K
82728 <1% 757 $11K
74018 <1% 324 $11K
97802 <1% 229 $10K
84702 <1% 607 $10K
87077 <1% 1,488 $10K
87088 <1% 1,869 $10K
86140 <1% 1,035 $10K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,278 $10K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 157 $10K
86803 <1% 554 $10K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 56 $9K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 10,942 $9K
83735 <1% 1,661 $9K
87340 <1% 446 $8K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 185 $8K
83516 <1% 422 $8K
94726 <1% 109 $8K
94729 <1% 109 $8K
82570 <1% 714 $7K
85610 <1% 1,695 $7K
72100 <1% 336 $7K
87205 <1% 908 $7K
80320 <1% 1,180 $7K
87186 <1% 1,466 $6K
73610 <1% 461 $6K
80076 <1% 1,633 $6K
73630 <1% 615 $6K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 27 $6K
83540 <1% 670 $6K
86235 <1% 431 $6K
87081 <1% 306 $6K
82784 <1% 578 $5K
93017 <1% 76 $5K
86901 <1% 918 $5K
96367 <1% 124 $5K
88304 <1% 244 $5K
84481 <1% 436 $5K
71045 Radiologic examination, chest; single view <1% 4,837 $5K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,420 $5K
73030 <1% 299 $5K
73564 <1% 268 $5K
85652 <1% 1,085 $5K
0001A <1% 224 $4K
86762 <1% 230 $4K
77067 Screening mammography, bilateral, including computer-aided detection <1% 430 $4K
72125 Computed tomography, cervical spine; without contrast material <1% 359 $4K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 29 $4K
92526 <1% 53 $4K
12001 <1% 36 $4K
76642 <1% 34 $4K
83615 <1% 614 $4K
81001 <1% 10,600 $4K
71271 <1% 25 $4K
83880 <1% 603 $4K
0002A <1% 189 $4K
86256 <1% 230 $4K
83550 <1% 536 $3K
82950 <1% 243 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 112 $3K
82043 <1% 401 $3K
73110 <1% 178 $3K
84484 <1% 4,085 $3K
90715 <1% 138 $2K
73130 <1% 272 $2K
84112 <1% 56 $2K
96375 Therapeutic injection; each additional sequential IV push <1% 6,554 $2K
76981 <1% 47 $2K
86225 <1% 165 $2K
82670 <1% 56 $2K
84153 <1% 104 $2K
93970 <1% 14 $2K
82248 <1% 199 $2K
83690 <1% 2,924 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 259 $2K
84156 <1% 354 $2K
36591 <1% 163 $2K
82140 <1% 169 $2K
96158 <1% 18 $2K
82746 <1% 230 $2K
92523 <1% 31 $2K
87522 Neg quan hep c or qual rna <1% 28 $2K
83001 <1% 79 $2K
73502 <1% 87 $1K
84146 <1% 70 $1K
88342 <1% 393 $1K
99152 <1% 18 $1K
84100 <1% 414 $1K
70551 Magnetic resonance imaging, brain; without contrast material <1% 16 $1K
82247 <1% 69 $1K
86480 <1% 21 $1K
96376 <1% 1,215 $1K
87075 <1% 288 $1K
88313 <1% 280 $968.40
84550 <1% 199 $936.92
82962 <1% 1,921 $932.02
82785 <1% 87 $922.00
83002 <1% 51 $917.89
85730 <1% 769 $915.47
84402 <1% 28 $789.15
86706 <1% 42 $785.52
86038 <1% 42 $776.61
86255 <1% 69 $742.31
86003 <1% 66 $741.85
80074 <1% 38 $731.69
99153 Mod sedat endo service >5yrs <1% 17 $681.92
70486 <1% 17 $631.99
85379 <1% 709 $597.28
80164 <1% 67 $589.97
84703 <1% 2,186 $586.34
80069 <1% 26 $543.66
86787 <1% 24 $524.88
84165 <1% 73 $488.95
81025 <1% 1,299 $484.79
81002 <1% 240 $479.68
99406 <1% 52 $477.65
87040 <1% 366 $459.61
83970 <1% 29 $437.29
82652 <1% 17 $385.46
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 21 $320.00
86376 <1% 14 $293.18
73080 <1% 42 $290.00
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 377 $261.84
87807 <1% 219 $224.64
86334 <1% 27 $223.90
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 239 $209.38
87428 <1% 1,152 $198.08
82550 <1% 69 $183.54
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 598 $182.38
83605 <1% 725 $180.81
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 9,960 $122.21
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 2,438 $120.01
72040 <1% 14 $116.78
84436 <1% 17 $87.07
82565 <1% 20 $79.74
84450 <1% 20 $62.02
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 15 $56.71
73590 <1% 32 $51.83
84460 <1% 19 $44.30
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 93 $44.14
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 543 $33.08
J7120 Ringers lactate infusion, up to 1000 cc <1% 105 $15.18
J7050 Infusion, normal saline solution, 250 cc <1% 645 $9.23
91300 <1% 431 $2.40
A9270 Non-covered item or service <1% 1,349 $1.22
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,622 $0.85
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg <1% 26 $0.20
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 88 $0.00
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 0% 54 $0.00
J7030 Infusion, normal saline solution , 1000 cc 0% 245 $0.00
00840 0% 14 $0.00
82077 0% 197 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 29 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOYES, SCOTT (DIRECTOR OF FISCAL SERVICES CFO)